ArticlePharmaceutics2021

The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy.

Wen Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.